Open AccessRange and consistency of outcome measures reported in randomised trials in dermatomyositis: a systematic review
Author(s) -
Amy H Kelly,
Davinder SinghGrewal,
Daniel Sumpton,
Geraldine Hasset,
Karine Manera,
Allison Tong
Publication year - 2022
Publication title -
clinical and experimental rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.184
H-Index - 95
eISSN - 1593-098X
pISSN - 0392-856X
DOI - 10.55563/clinexprheumatol/3izscd
Subject(s) - medicine , dermatomyositis , juvenile dermatomyositis , clinical trial , physical therapy , medline , randomized controlled trial , meta analysis , quality of life (healthcare) , nursing , political science , law
Dermatomyositis (DM) and juvenile dermatomyositis (JDM) are idiopathic inflammatory myopathies, which can be resistant and unresponsive to initial treatments, leading to severe complications and impaired quality of life. There are few randomised trials in dermatomyositis and the outcomes reported may not be consistent, which can limit decision-making. The aim of this study is to assess the scope and consistency of outcomes reported in randomised trials in dermatomyositis.